TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 12 filers reported holding TRANSCODE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,770 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,289,000 | $1,418,000 | 0.44% |
| Worth Venture Partners, LLC | 324,157 | $357,000 | 0.22% |
| Redmond Asset Management, LLC | 90,874 | $100,000 | 0.04% |
| ACT CAPITAL MANAGEMENT, LLC | 6,500 | $7,000 | 0.01% |
| K.J. Harrison & Partners Inc | 19,987 | $22,000 | 0.01% |
| Shay Capital LLC | 15,060 | $17,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 76,549 | $84,000 | 0.00% |
| STATE STREET CORP | 21,019 | $23,000 | 0.00% |
| BlackRock Inc. | 15,334 | $17,000 | 0.00% |